SLGN CEO Greenlee bought 7,000 shares at $38.19; stock down 32.5% from 52-week high, -9.1% in 30 days.
CEO Adam J Greenlee purchased 7,000 shares at $38.19 on 2025-10-31, increasing holdings by 2.2% to 328,164 shares total. The purchase occurs while SILGAN Holdings trades at $38.85, down 32.5% from its 52-week high of $57.53, with a -9.1% 30-day decline. Fundamentally, the company maintains a 13.78 P/E ratio with $1.5B quarterly revenue and a -2.2% annual revenue growth rate. His cross-ticker track record shows 1 prior sell at a 100.00% well-timed rate with a 90-day return of -0.5%, while his same-ticker prior sale on 2025-02-24 matched these outcomes (30d -6.8%, 90d -0.5%). The purchase follows a significant price decline but does not trigger any of the timing patterns his prior sales have demonstrated; this trade's significance lies in its scale relative to existing holdings and the current depressed price environment.
SLGN CEO Adam J Greenlee sold 125,000 shares for $6.8M; reduces holdings by 35.5% to 227.3K shares
Adam J Greenlee, President and CEO, executed a large discretionary sale of 125,000 shares at $54.73, reducing his holdings by 35.5% from 352.3K shares to 227.3K shares. The sale occurs near the upper end of the 52-week range ($41.32–$57.53), approximately 4.9% below the 52-week high. The company's fundamentals show mixed signals: revenue declined 6.6% year-over-year, while net income remains substantial at $100.1M on $1.7B quarterly revenue, and the stock trades at a P/E of 19.75. The CEO's substantial reduction in personal shareholding warrants investor attention given the significant stake disposition and the concurrent operating headwinds.